Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. A Southwest Oncology Group study

Invest New Drugs. 1990 Aug;8(3):307-9. doi: 10.1007/BF00171843.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Drug Evaluation
  • Female
  • Humans
  • Infusions, Intravenous
  • Interferon-gamma / administration & dosage
  • Interferon-gamma / therapeutic use*
  • Interferon-gamma / toxicity
  • Kidney Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Recombinant Proteins

Substances

  • Recombinant Proteins
  • Interferon-gamma